'Arimidex' (anastrozole) versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer-efficacy overview

By Buzdar A.U.   On behalf of ATAC trialists' group  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 399-403

Elsevier

Access to resources Recommend Favorite

Letrozole versus tamoxifen in the treatment of advanced breast cancer and as neoadjuvant therapy

By Smith I.E.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 289-293

Elsevier

Access to resources Recommend Favorite

Aromatase inhibitors versus tamoxifen for management of postmenopausal breast cancer in the advanced disease and neoadjuvant settings

By Ingle J.N.   Suman V.J.  

The Journal of Steroid Biochemistry and Molecular Biology, Vol. 86, Iss. 3, 2003-09 ,pp. : 313-319

Elsevier

Access to resources Recommend Favorite

Tamoxifen enhances interferon-regulated gene expression in breast cancer cells

By Lindner D.J.   Kolla V.   Kalvakolanu1 D.V.   Borden E.C.  

Molecular and Cellular Biochemistry, Vol. 167, Iss. 1-2, 1997-01 ,pp. : 169-177

Springer Publishing Company

Access to resources Recommend Favorite

A new marker of tamoxifen resistance of estrogen receptor-positive breast cancer

By Bogush E.   Ravcheeva A.   Bogush T.   Zabotina T.   Kadagidze Z.   Davydov M.  

Doklady Biochemistry & Biophysics, Vol. 413, Iss. 1, 2007-04 ,pp. : 83-87

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite